Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
- Status
- RECRUITING
- Phase
- PHASE2
Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.
- Status
- COMPLETED
- Phase
- N/A
The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- NA
Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients
- Status
- RECRUITING
- Phase
- PHASE2
Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC)
- Status
- RECRUITING
- Phase
- PHASE2
Cryoablation+Ipilimumab+Nivolumab in Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Neoantigen Derived DCs as Cancer Treatment
- Status
- RECRUITING
- Phase
- PHASE1
Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN
- Status
- WITHDRAWN
- Phase
- PHASE2
Immunotherapy in Patients With Early dMMR Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung
- Status
- WITHDRAWN
- Phase
- PHASE1
Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE2
EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma
- Status
- COMPLETED
- Phase
- N/A
Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
- Status
- COMPLETED
- Phase
- EARLY_PHASE1